122 related articles for article (PubMed ID: 2429788)
1. Functional activities and nonenzymatic glycosylation of plasma proteinase inhibitors in diabetes.
Hall P; Tryon E; Nikolai TF; Roberts RC
Clin Chim Acta; 1986 Oct; 160(1):55-62. PubMed ID: 2429788
[TBL] [Abstract][Full Text] [Related]
2. Influence of plasma protease inhibitors and the secretory leucocyte protease inhibitor on leucocyte elastase-induced consumption of selected plasma proteins in vitro in man.
Björk P; Axelsson L; Bergenfeldt M; Ohlsson K
Scand J Clin Lab Invest; 1988 Apr; 48(2):205-11. PubMed ID: 2451859
[TBL] [Abstract][Full Text] [Related]
3. Isolation of nine human plasma proteinase inhibitors by sequential affinity chromatography.
Dubin A; Potempa J; Travis J
Prep Biochem; 1990; 20(1):63-74. PubMed ID: 1694995
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of altered antithrombin III activity due to nonenzymatic glycosylation at glucose concentration expected to be encountered in severely diabetic patients.
Villanueva GB; Allen N
Diabetes; 1988 Aug; 37(8):1103-7. PubMed ID: 3391345
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human activated Factor X by antithrombin III and alpha 1-proteinase inhibitor in human plasma.
Gitel SN; Medina VM; Wessler S
J Biol Chem; 1984 Jun; 259(11):6890-5. PubMed ID: 6202686
[TBL] [Abstract][Full Text] [Related]
6. Blood levels of proteinase inhibitors in pregnancy.
Walker JE; Campbell DM; Ogston D
Br J Obstet Gynaecol; 1982 Mar; 89(3):208-10. PubMed ID: 6175337
[TBL] [Abstract][Full Text] [Related]
7. Blood levels of proteinase inhibitors in pre-eclampsia.
Gow L; Campbell DM; Ogston D
Br J Obstet Gynaecol; 1983 Oct; 90(10):950-2. PubMed ID: 6194812
[TBL] [Abstract][Full Text] [Related]
8. Antithrombin III activity and concentration in diabetes mellitus.
Patrassi GM; Picchinenna R; Vettor R; Cappellato G; Coccarielli D; Girolami A
Thromb Haemost; 1985 Aug; 54(2):415-7. PubMed ID: 3936213
[TBL] [Abstract][Full Text] [Related]
9. Non enzymatic glycosylation of alpha-1-proteinase inhibitor of human plasma.
Phadke M; Billimoria FR; Ninjoor V
J Postgrad Med; 1998; 44(2):29-34. PubMed ID: 10703566
[TBL] [Abstract][Full Text] [Related]
10. Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation--a preliminary report.
Ceriello A; Dello Russo P; Zuccotti C; Florio A; Nazzaro S; Pietrantuono C; Rosato GB
Thromb Haemost; 1983 Oct; 50(3):633-4. PubMed ID: 6648886
[TBL] [Abstract][Full Text] [Related]
11. The effect of phosphatidylserine on the inhibition of human factor Xa by the plasma proteinase inhibitors.
Friedberg RC; Pizzo SV
Thromb Res; 1988 Jun; 50(6):901-6. PubMed ID: 3261898
[No Abstract] [Full Text] [Related]
12. Protease inhibitors in plasma and faecal extracts from patients with active inflammatory bowel disease.
Bohe M; Genell S; Ohlsson K
Scand J Gastroenterol; 1986 Jun; 21(5):598-604. PubMed ID: 2428096
[TBL] [Abstract][Full Text] [Related]
13. Improved prognosis of fulminant hepatic failure (FHF) after plasma derivative replacement therapy. Enhanced proteolysis of hemostatic proteins confirmed by proteinase-inhibitor complexes determination.
Egbring R; Seitz R
Z Gastroenterol; 1990 Feb; 28(2):104-9. PubMed ID: 2138832
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitors of hemostasis in diabetes mellitus].
González R; Alegre A; Alberca I; Vicente V; López Borrasca A
Sangre (Barc); 1986; 31(2):156-60. PubMed ID: 2425438
[No Abstract] [Full Text] [Related]
15. Components of the kallikrein-kinin-system in patients with ARDS.
Fuhrer G; Heller W; Junginger W; Gröber O; Roth K
Prog Clin Biol Res; 1989; 308():737-42. PubMed ID: 2476827
[No Abstract] [Full Text] [Related]
16. Oxidative inactivation of purified human alpha-2-antiplasmin, antithrombin III, and C1-inhibitor.
Stief TW; Aab A; Heimburger N
Thromb Res; 1988 Mar; 49(6):581-9. PubMed ID: 2455361
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of human plasma serine proteinase inhibitors (serpins) by limited proteolysis of the reactive site loop with snake venom and bacterial metalloproteinases.
Kress LF
J Cell Biochem; 1986; 32(1):51-8. PubMed ID: 2429973
[TBL] [Abstract][Full Text] [Related]
18. Human monocytes release plasma serine protease inhibitors in vitro.
Kłoczko J; Bielawiec M; Giedrojć J; Radziwon P; Galar M
Haemostasis; 1990; 20(4):229-32. PubMed ID: 1700759
[TBL] [Abstract][Full Text] [Related]
19. Metabolic control may alter antithrombin III activity but not its plasma concentration in diabetes: a possible role for nonenzymatic glycosylation.
Ceriello A; Giugliano D; Dello Russo P; Tirelli A; Passariello N; Sgambato S
Diabetes Care; 1986; 9(1):32-5. PubMed ID: 3948645
[TBL] [Abstract][Full Text] [Related]
20. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
